ArticleCancer biology & therapy2011

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.

Georg Feldmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.